Your browser doesn't support javascript.
loading
CXCR4 chemokine antagonist scores a first FDA approval for WHIM syndrome.
Nat Rev Drug Discov ; 23(6): 411, 2024 06.
Article in En | MEDLINE | ID: mdl-38740965

Full text: 1 Collection: 01-internacional Database: MEDLINE Main subject: United States Food and Drug Administration / Drug Approval / Receptors, CXCR4 / Primary Immunodeficiency Diseases Limits: Humans Country/Region as subject: America do norte Language: En Journal: Nat Rev Drug Discov Journal subject: FARMACOLOGIA / TERAPIA POR MEDICAMENTOS Year: 2024 Document type: Article Country of publication: United kingdom

Full text: 1 Collection: 01-internacional Database: MEDLINE Main subject: United States Food and Drug Administration / Drug Approval / Receptors, CXCR4 / Primary Immunodeficiency Diseases Limits: Humans Country/Region as subject: America do norte Language: En Journal: Nat Rev Drug Discov Journal subject: FARMACOLOGIA / TERAPIA POR MEDICAMENTOS Year: 2024 Document type: Article Country of publication: United kingdom